- Clone
- 1A1 (See other available formats)
- Regulatory Status
- RUO
- Other Names
- TNFRSF13B, CD267, Transmembrane Activator and CAML Interactor (TACI)
- Isotype
- Rat IgG2a, κ
- Barcode Sequence
- AGTGATGGAGCGAAC
Cat # | Size | Price | Quantity Check Availability | ||
---|---|---|---|---|---|
311917 | 10 µg | $369.00 |
TACI, Transmembrane Activator CAML (calcium modulator and cyclophilin ligand) Interactor, is a 32 kD type III transmembrane protein. It belongs to TNF receptor superfamily, known as TNFRSF member 13B (TNFRSF13B) or CD267. TACI is expressed on B cells, and myeloma cells. TACI contains 2 cysteine-rich domains (CRDs). Recent studies, however, have shown that another shorter form (TACI_d2) of TACI exists wherein the N-terminal CRD is removed by alternative splicing. TACI_d2 contains full affinity for its ligands. Several proteins (BAFF/BLys, APRIL, Syndecan-2) have been identified as TACI ligands. The interaction of TACI with its ligands induces activation of the transcription factors NFAT, AP1, and NF-κ B and plays a crucial role in humoral immunity by negative regulation of B cell proliferation and survival.
Product Details
- Verified Reactivity
- Human
- Reported Reactivity
- African Green, Baboon, Cynomolgus, Rhesus
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- TACI-transfected RBL cells
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
- Preparation
- The antibody was purified by chromatography and conjugated with TotalSeq™-B oligomer under optimal conditions.
- Concentration
- 0.5 mg/mL
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
- Application
-
PG - Quality tested
- Recommended Usage
-
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis and the oligomer sequence is confirmed by sequencing. TotalSeq™-B antibodies are compatible with 10x Genomics Single Cell Gene Expression Solutions.
To maximize performance, it is strongly recommended that the reagent be titrated for each application, and that you centrifuge the antibody dilution before adding to the cells at 14,000xg at 2 - 8°C for 10 minutes. Carefully pipette out the liquid avoiding the bottom of the tube and add to the cell suspension. For Proteogenomics analysis, the suggested starting amount of this reagent for titration is ≤ 1.0 µg per million cells in 100 µL volume. Refer to the corresponding TotalSeq™ protocol for specific staining instructions.
Buyer is solely responsible for determining whether Buyer has all intellectual property rights that are necessary for Buyer's intended uses of the BioLegend TotalSeq™ products. For example, for any technology platform Buyer uses with TotalSeq™, it is Buyer's sole responsibility to determine whether it has all necessary third party intellectual property rights to use that platform and TotalSeq™ with that platform. - Additional Product Notes
-
TotalSeq™ reagents are designed to profile protein levels at a single cell level following an optimized protocol similar to the CITE-seq workflow. A compatible single cell device (e.g. 10x Genomics Chromium System and Reagents) and sequencer (e.g. Illumina analyzers) are required. Please contact technical support for more information, or visit biolegend.com/totalseq.
The barcode flanking sequences are GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNNNNNNNN (PCR handle), and NNNNNNNNNGCTTTAAGGCCGGTCCTAGC*A*A (capture sequence). N represents either randomly selected A, C, G, or T, and * indicates a phosphorothioated bond, to prevent nuclease degradation.
View more applications data for this product in our Scientific Poster Library. -
Application References
(PubMed link indicates BioLegend citation) -
- Ng LG, et al.2004. J. Immunol. 173:807. (FC)
- Lougaris V, et al. 2012. Hum Immunol. 73:836. PubMed.
- RRID
-
AB_2890746 (BioLegend Cat. No. 311917)
Antigen Details
- Structure
- Type III transmembrane protein, TNF receptor superfamily, 32 kD
- Distribution
-
B cells, meyloma cells
- Function
- Negative regulation of B cell function
- Ligand/Receptor
- BAFF/BLys, April, Syndecan-2
- Cell Type
- B cells
- Biology Area
- Costimulatory Molecules, Immunology
- Molecular Family
- CD Molecules
- Antigen References
-
1. Gross JA, et al. 2000. Nature 404:995.
2. Wu Y, et al. 2000. J. Biol Chem. 275:35478.
3. Yan M, et al. 2001. Nat. Immunol. 2:638.
4. Hymowitz A, et al. 2005. J. Biol. Chem. 280:7218.
5. Bischof D, et al. 2006. BLOOD 107:3235. - Gene ID
- 23495 View all products for this Gene ID
- UniProt
- View information about CD267 on UniProt.org
Other Formats
View All CD267 Reagents Request Custom ConjugationDescription | Clone | Applications |
---|---|---|
Purified anti-human CD267 (TACI) | 1A1 | FC |
Biotin anti-human CD267 (TACI) | 1A1 | FC |
PE anti-human CD267 (TACI) | 1A1 | FC |
PE/Cyanine7 anti-human CD267 (TACI) | 1A1 | FC |
PE/Dazzle™ 594 anti-human CD267 (TACI) | 1A1 | FC |
APC anti-human CD267 (TACI) | 1A1 | FC |
TotalSeq™-A0247 anti-human CD267 (TACI) | 1A1 | PG |
TotalSeq™-C0247 anti-human CD267 (TACI) | 1A1 | PG |
TotalSeq™-B0247 anti-human CD267 (TACI) Antibody | 1A1 | PG |
Compare Data Across All Formats
This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.
-
Purified anti-human CD267 (TACI)
-
Biotin anti-human CD267 (TACI)
-
PE anti-human CD267 (TACI)
-
PE/Cyanine7 anti-human CD267 (TACI)
-
PE/Dazzle™ 594 anti-human CD267 (TACI)
-
APC anti-human CD267 (TACI)
-
TotalSeq™-A0247 anti-human CD267 (TACI)
-
TotalSeq™-C0247 anti-human CD267 (TACI)
-
TotalSeq™-B0247 anti-human CD267 (TACI) Antibody